Seqker Biosciences, Inc.
2 clinical trials · Sponsor
◉ Watch Seqker Biosciences, Inc.
| Record | Firm | Date |
|---|---|---|
| Personalized Neoantigen Peptide Vaccines for Solid Tumors (NCT07002203) | Seqker Biosciences, Inc. | 2024-03-01 |
| Personalized Neoantigen Cancer Vaccine for Patients With Solid Tumors (NCT06614140) | Seqker Biosciences, Inc. | 2022-11-24 |
Track Seqker Biosciences, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.